Suppr超能文献

运动性中暑期间布洛芬的影响。

Effects of Ibuprofen during Exertional Heat Stroke in Mice.

机构信息

Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL.

出版信息

Med Sci Sports Exerc. 2020 Sep;52(9):1870-1878. doi: 10.1249/MSS.0000000000002329.

Abstract

UNLABELLED

Intestinal injury is one of the most prominent features of organ damage in exertional heat stroke (EHS). However, whether damage to the intestine in this setting is exacerbated by ibuprofen (IBU), the most commonly used nonsteroidal anti-inflammatory drug in exercising populations, is not well understood.

PURPOSE

We hypothesized that IBU would exacerbate intestinal injury, reduce exercise performance, and increase susceptibility to heat stroke.

METHODS

To test this hypothesis, we administered IBU via diet to male and female C57/BL6J mice, over 48 h before EHS. Susceptibility to EHS was determined by assessing exercise response using a forced running wheel, housed inside an environmental chamber at 37.5°C. Core temperature (Tc) was monitored by telemetry. Mice were allocated into four groups: exercise only (EXC); EHS + IBU; EXC + IBU; and EHS only. Exercise performance and Tc profiles were evaluated and stomachs, intestines and plasma were collected at 3 h post-EHS.

RESULTS

The EHS + IBU males ran approximately 87% longer when Tc was above 41°C (P < 0.03) and attained significantly higher peak Tc (P < 0.01) than EHS-only mice. Histological analyses showed decreased villi surface area throughout the small intestine for both sexes in the EXC + IBU group versus EXC only. Interestingly, though EHS in both sexes caused intestinal injury, in neither sex were there any additional effects of IBU.

CONCLUSIONS

Our results suggest that in a preclinical mouse model of EHS, oral IBU at pharmacologically effective doses does not pose additional risks of heat stroke, does not reduce exercise performance, and does not contribute further to intestinal injury, though this could have been masked by significant gut injury induced by EHS alone.

摘要

未加标签

在运动性热射病(EHS)中,肠损伤是器官损伤最显著的特征之一。然而,在这种情况下,肠道是否会因布洛芬(IBU)而加重,IBU 是运动人群中最常用的非甾体抗炎药,目前还不太清楚。

目的

我们假设 IBU 会加重肠损伤,降低运动表现,并增加热射病的易感性。

方法

为了验证这一假设,我们通过饮食在 EHS 前 48 小时向雄性和雌性 C57/BL6J 小鼠给予 IBU。通过在 37.5°C 的环境室内使用强制跑步轮来评估运动反应,来确定对 EHS 的易感性。通过遥测监测核心温度(Tc)。将小鼠分为四组:仅运动(EXC);EHS+IBU;EXC+IBU;和 EHS 仅。评估运动表现和 Tc 曲线,并在 EHS 后 3 小时收集胃、肠和血浆。

结果

当 Tc 高于 41°C 时,EHS+IBU 雄性的跑步时间约长 87%(P < 0.03),达到的 Tc 峰值明显更高(P < 0.01)比 EHS 组。组织学分析显示,在 EXC+IBU 组,两性的小肠绒毛表面积均减小。有趣的是,尽管 EHS 在两性中都导致了肠损伤,但 IBU 并没有增加肠损伤的额外影响。

结论

我们的结果表明,在 EHS 的临床前小鼠模型中,口服药理学有效剂量的 IBU 不会增加热射病的风险,不会降低运动表现,也不会进一步加重肠损伤,尽管这可能被 EHS 单独引起的严重肠道损伤所掩盖。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验